MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER
Date
2016-04
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Abstract
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Scales, Charles, Melissa Greiner, Lesley Curtis, Brad Hammill, Andrew Peterson, Cindy Amundsen, Viviana Martinez-Bianchi, Mitchell Heflin, et al. (2016). MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER. The Journal of Urology, 195(4). p. e285. 10.1016/j.juro.2016.02.793 Retrieved from https://hdl.handle.net/10161/12930.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke

Lesley H. Curtis
Lesley H. Curtis is Professor in the Departments of Population Health Sciences and Medicine in the Duke School of Medicine and was inaugural chair of the Department of Population Health Sciences. A health services researcher by training, Dr. Curtis is an expert in the use of health care and Medicare claims data for health services and clinical outcomes research, and a leader in national data quality efforts. Dr. Curtis has led the linkage of Medicare claims with several large clinical registries and epidemiological cohort studies including the Framingham Heart Study and the Cardiovascular Health Study. Dr. Curtis currently serves as a senior policy advisor at the Food and Drug Administration supporting the Agency’s evidence generation initiative, and is co-PI of the NIH Pragmatic Trials Collaboratory, an NIH initiative to strengthen the national capacity for large-scale research studies embedded in health care delivery.
Areas of expertise: Health Services Research and Health Policy

Cindy Louise Amundsen
- Treatment with a minimally invasive neural modulation system (sacral and posterior tibial nerve) for control of urinary continence
- Application of botox therapy for urinary urge incontinence
- Evaluation and treatment for nocturnal voiding
- Application of nerve stimulation for urinary retention
- Minimally invasive prolapse surgery for pelvic organ prolapse repairs
- Treatment for stress urinary incontinence with minimally invasive techniques
- Evaluation of the urinary microbiome as it relates to recurrent urinary tract infections and lower urinary tract symptoms

Viviana Sandra Martinez-Bianchi
Health Disparities, Access to Health Care, Women's Health, Latino Health Care, Chronic Disease Management, Socioeconomic Determinants of Health. Population Health.

Kenneth Edwin Schmader
Dr. Schmader’s areas of research include herpes zoster, infections, and vaccines in older adults. He conducts translational, clinical trials and observational studies of zoster, influenza, and other infections funded by grants from the National Institute on Aging (NIA), National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control (CDC), VA Office of Research and Development, and Industry sources. He has played a pivotal role in the development of zoster vaccines in older adults. Dr. Schmader also performs research in medications and older adults, focusing on pharmacoepidemiology, optimal drug use and reduction of adverse drug reactions.
He is the Director of the NIA-funded P30 Duke Pepper Older Americans Independence Center, Co-investigator of the NIAID funded Collaborative Influenza Vaccine Innovation Centers (CIVICS) and the CDC Clinical Immunization Safety Assessment (CISA) office at Duke. He serves on the Working Groups for the Herpes Zoster, Influenza, COVID-19, RSV and General Adult Immunization Guidelines for the US Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) and is the American Geriatrics Society liaison to the ACIP.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.